![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. 937263-71-3
2. Mfcd28977540
3. 3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)aniline
4. 4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylbenzenamine
5. 3-methyl-4-{[1,2,4]triazolo[1,5-a]pyridin-7-yloxy}aniline
6. Schembl1192195
7. Akos026674005
8. At27623
9. Sb18464
10. Bs-50410
11. Sy274772
Molecular Weight | 240.26 g/mol |
---|---|
Molecular Formula | C13H12N4O |
XLogP3 | 2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 2 |
Exact Mass | 240.10111102 g/mol |
Monoisotopic Mass | 240.10111102 g/mol |
Topological Polar Surface Area | 65.4 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 288 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.